Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Pharmaceutical giants Moderna and Merck said that an experimental vaccine treatment has shown signs of preventing skin cancer from returning or spreading in a study of melanoma patients.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.nbcnews.com — the content belongs to NBC News.
